Influence of vitamin D3 analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts

Acta Biochimica Polonica

Volumn 56, Issue 2, 2009, Pages 235-242

  Rostkowska Nadolska, Beata ^a   Fra̧czek, Marcin ^a   Gawron, Wojciech ^a   Latocha, Małgorzata ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Budesonid R; Calcitriol; Fibroblast; Nasal polyps; Proliferation; Tacalcitol; Vitamin D3

Indexed keywords

BOVINAE;

EID: 68349121484     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2009_2454     Document Type: Article

References (30)

1. Audo I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM (2003) Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci 44: 4192-4199.
2. 3 with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res 7: 4164-4173.
3. Evans RM (1998) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
4. Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K (1998) Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol). Br J Pharmacol 124: 1433-1438.
5. 3: dependence on cell culture condition. J Invest Dermatol 106: 510-516.
6. Gruber BM, Januszewska EL (2002) Influence of vitamin D3 metabolites on cell proliferation and cytotoxicity of adriamycin in human normal and neoplastic cells. Toxicol Vitro 16: 663-667.
7. Hansen CM, Mäenpää PH (1997) EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem Pharmacol 54: 1173-1179.
8. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59: 2644-2649.
9. Holick MF (1984) The photobiology of vitamin D3 in man In Vitamin D: Basic and Clinical Aspects. Kuman R, ed, pp 197-216. Martinus Nijhoff Boston.
10. James SY, Mackay AG, Colston KW (1996) Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 58: 395-401.
11. Johnson CS, Hershberger PA, Trump DL (2002) Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev 21: 147-158.
12. Koli K, Keski-Oja J (1995) 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 55: 1540-1546.
13. Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM (2007) Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol 6: 428-435.
14. Leone G, Pacifico A (2005) Profile of clinical efficacy and safety of topical tacalcitol. Acta Biomed 76: 13-19.
15. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C (2001) Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids 66: 171-176.
16. 3-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem 276: 26365-26373.
17. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU (2007) 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 103: 533-537.
18. Norlander T, Brönnegård M, Stierna P (1999) The relationship of nasal polyps, infection, and inflammation. Am J Rhinol 13: 349-355.
19. Pawankar R (2003) Nasal polyps: an update: editorial review. Curr Opin Allergy Clin Immunol 3: 1-6.
20. Pourgholami MH, Akhter J, Lu Y, Morris DL (2000) In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3. Cancer Lett 151: 97-102.
21. Rinia AB, Kostamo K, Ebbens FA, van Drunen CM, Fokkens WJ (2007) Nasal polyposis: a cellular-based approach to answering questions. Allergy 62: 348-358.
22. Rocker D, Ravid A, Liberman UA, Garach-Jehoshua O, Koren R (1994) 1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol Cell Endocrinol 106: 157-162.
23. Rostkowska-Nadolska B, Szymaniec S, Fortuna W, Szelejewski W, Uszycka-Horawa T, Zakrzewska-Karniewicz H (2002) Patent Number P-358032 (Zastosowanie 22R-16α,17α-butylidenodioksy-11-β,21-dihydroksy-1,4-pre gnadien-3,20-dionu jako środka antyproliferacyjnego w terapii polipów nosowych. Zgłoszenie patentowe numer P-358032; in Polish).
24. Rostkowska-Nadolska B, Preś K, Orendorz-Fraczkowska K (2005) 22R-16α, 17α-butylidenodioxy-11(,21-dihydroxy-1,4-pregnadien-3,20-dione - nasal water spray in prevention and treatment nasal polyposis. Adv Clin Exp Med 14: 497-503.
25. Ruzicka T, Trompke C (2004) Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion. Hautarzt 55: 165-170.
26. Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK (1993) Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drugs 4: 201-208.
27. Sprenger CC, Peterson A, Lance R, Ware JL, Drivdahl RH, Plymate SR (2001) Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3. J Endocrinol 170: 609-618.
28. Takahashi H, Ibe M, Kinouchi M, Ishida-Yamamoto A, Hashimoto Y, Iizuka H (2003) Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 31: 21-28.
29. Wu G, Fan RS, Li W, Ko TC, Brattain MG (1997) Modulation of cell cycle control by vitamin D3 and its analogue, EB 1089, in human breast cancer cells. Oncogene 15: 1555-1563.
30. Yu WD, McElwain MC, Modzelewski RA (1998) Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 90: 134-141.